Pharmaceutical Co-Crystals

Journal of Pharmaceutical Sciences - Tập 95 Số 3 - Trang 499-516 - 2006
P. Vishweshwar1, Jennifer A. McMahon1, J.A. Bis1, Michael J. Zaworotko1
1Department of Chemistry, University of South Florida, CHE205, 4202 East Fowler Avenue, Tampa, Florida 33620

Tóm tắt

Từ khóa


Tài liệu tham khảo

Haleblian, 1975, Characterization of habits and crystalline modification of solids and their pharmaceutical applications, J Pharm Sci, 64, 1269, 10.1002/jps.2600640805

Walsh, 2003, Crystal engineering of the composition of pharmaceutical phases, Chem Commun, 186, 10.1039/b208574g

Fleischman, 2003, Crystal engineering of the composition of pharmaceutical phases: Multiple-component crystalline solids involving carbamazepine, Cryst Growth Des, 3, 909, 10.1021/cg034035x

McMahon, 2005, Crystal engineering of the composition of pharmaceutical phases 3. Primary amide supramolecular heterosynthons and their role in the design of pharmaceutical co-crystals, Z Kristallogr, 220, 340, 10.1524/zkri.220.4.340.61624

Almarsson, 2004, Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?, Chem Commun, 1889, 10.1039/b402150a

Vishweshwar, 2005, Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients, Chem Commun, 4601, 10.1039/b501304f

Remenar, 2003, Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids, J Am Chem Soc, 125, 8456, 10.1021/ja035776p

Morissette, 2004, High-throughput crystallization: Polymorphs, salts, co-crystals and solvates of pharmaceutical solids, Adv Drug Del Rev, 56, 275, 10.1016/j.addr.2003.10.020

Childs, 2004, Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids, J Am Chem Soc, 126, 13335, 10.1021/ja048114o

Bettinetti, 2000, Structure and solid-state chemistry of anhydrous and hydrated crystal forms of the trimethoprim-sulfamethoxypyridazine 1:1 molecular complex, J Pharm Sci, 89, 478, 10.1002/(SICI)1520-6017(200004)89:4<478::AID-JPS5>3.0.CO;2-5

Zerkowski, 1997, Polymorphic packing arrangements in a class of engineered organic crystals, Chem Mat, 9, 1933, 10.1021/cm9505660

Almarsson, 2003, High-throughput surveys of crystal form diversity of highly polymorphic pharmaceutical compounds, Cryst Growth Des, 3, 927, 10.1021/cg034058b

Datta, 2004, Crystal structure of drugs: Advances in determination, prediction and engineering, Nat Rev Drug Discov, 3, 42, 10.1038/nrd1280

Oswald, 2002, The formation of paracetamol (acetaminophen) adducts with hydrogen-bonded acceptors, Acta Crystallogr, B58, 1057, 10.1107/S0108768102015987

Trask, 2004, Solvent-drop grinding: Green polymorph control of cocrystallization, Chem Commun, 890, 10.1039/b400978a

Trask, 2005, Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration, Cryst Growth Des, 5, 1013, 10.1021/cg0496540

Wöhler, 1844, Untersuchungen über das chinon, Annalen, 51, 153, 10.1002/jlac.18440510202

Ling, 1893, Halogen derivatives of quinone Part III. Derivatives of quinhydrone, J Chem Soc, 63, 1314, 10.1039/CT8936301314

Kitaigorodskii, 1984

Dunitz, 2003, Crystal and co-crystal: A second opinion, Cryst Eng Comm, 4, 506, 10.1039/b315687g

Desiraju, 2003, Crystal and co-crystal, Cryst Eng Comm, 5, 466, 10.1039/b313552g

Aakeröy, 2005, Building co-crystals with molecular sense and supramolecular sensibility, Cryst Eng Comm, 7, 439, 10.1039/b505883j

Seddon, 2004, Pseudopolymorph: A Polemic, Cryst Growth Des, 4, 1087, 10.1021/cg030084y

Desiraju, 2004, Counterpoint: What's in the name?, Cryst Growth Des, 4, 1089, 10.1021/cg030085q

Bernstein, 2005, …And another comment on Pseudopolymorphism, Cryst Growth Des, 5, 1661, 10.1021/cg058007l

Nangia, 2005, Pseudopolymorph: Retain this widely accepted term, Cryst Growth Des, 5

Buck, 1931, Mixed benzoins VI. Further examples of reversibility. The formation of addition compounds, J Am Chem Soc, 53, 2784, 10.1021/ja01358a052

Anderson, 1937, Structure of organic molecular compounds, Nature, 140, 583, 10.1038/140583b0

Remyga, 1969, Examples of mixed binary molecular crystal with double statistical disorder in the arrangement of molecules, Z Strukturnoi Khimii, 10, 1131

Van Niekerk, 1948, The crystal structure of the molecular complex of 4,4′-dinitrobiphenyl with biphenyl, Acta Crystallogr, 1, 44, 10.1107/S0365110X48000107

Hall, 1967, 2:1 solid-state complex of hexamethylbenzene:tetracyanoethylene, J Phys Chem, 71, 465, 10.1021/j100861a051

Pekker, 2005, Rotor-stator molecular crystals of fullerenes and cubane, Nature Mat, 4, 764, 10.1038/nmat1468

Allen, 1993, 3D Search and research using the Cambridge Structural Database, Chem Des Automat News, 8, 31

Huang, 1997, A novel class of phenol-pyridine co-crystals for second harmonic generation, J Mater Chem, 7, 713, 10.1039/a604311j

Gao, 2004, Supramolecular construction of molecular ladders in the solid state, Angew Chem Int Ed, 43, 232, 10.1002/anie.200352713

Xiao, 2000, A supramolecular solution to a long-standing problem: The 1,6-polymerization of a triacetylene, Angew Chem Int Ed, 39, 2132, 10.1002/1521-3773(20000616)39:12<2132::AID-ANIE2132>3.0.CO;2-8

Ma, 2002, Structural variation and supramolecular isomerism in the C-Methylcalix[4]resorcinarene/bipyridine system, Cryst Growth Des, 2, 7, 10.1021/cg0155595

MacGillivray, 2001, Conformational isomerism leads to supramolecular isomerism and nanoscale inclusion in 2D extended framework solids based on C-methylcalix[4]resorcinarene, Chem Commun, 1034, 10.1039/b102856c

MacGillivray, 2000, Encapsulation of two aromatics by a carcerand-like capsule of nanometer-scale dimension, Chem Commun, 359, 10.1039/a909339g

Taylor, 1994, Process and composition for use in photographic materials containing hydroquinones

Pepinsky, 1955, Crystal engineering: New concepts in crystallography, Phys Rev, 100, 971

Schmidt, 1971, Photodimerization in the solid state, Pure Appl Chem, 27, 647, 10.1351/pac197127040647

Desiraju, 1989

Lehn, 1995

Moulton, 2001, From molecules to crystal engineering: Supramolecular isomerism and polymorphism in networks, Chem Rev, 101, 1629, 10.1021/cr9900432

Zaworotko, 2001, Superstructural diversity in two dimensions: Crystal engineering of laminated solids, Chem Commun, 1, 10.1039/b007127g

Eddaoudi, 2001, Modular chemistry: Secondary building units as a basis for the design of highly porous and robust metal-organic carboxylate frameworks, Acc Chem Res, 34, 319, 10.1021/ar000034b

Kitagawa, 2004, Functional porous coordination polymers, Angew Chem Int Ed, 43, 2334, 10.1002/anie.200300610

Janiak, 2003, Engineering coordination polymers towards applications, J Chem Soc Dalton Trans, 14, 2781, 10.1039/b305705b

James, 2003, Metal-organic frameworks, Chem Soc Rev, 32, 276, 10.1039/b200393g

Oh, 2003, A novel 3D brick-wall coordination network based on nodes with square-pyramidal connectivity, Angew Chem Int Ed, 42, 2026, 10.1002/anie.200250637

Braga, 1998, Crystal engineering and organometallic architecture, Chem Rev, 98, 1375, 10.1021/cr960091b

Hosseini, 2003, Molecular tectonics: From molecular recognition of anions to molecular networks, Coord Chem Rev, 240, 157, 10.1016/S0010-8545(03)00021-3

Melendez, 1998, Hydrogen-bonded ribbons, tapes and sheets as motifs for crystal engineering, Top Curr Chem, 198, 97, 10.1007/3-540-69178-2_3

Desiraju, 1995, Supramolecular synthons in crystal engineering—A new organic synthesis, Angew Chem Int Ed, 34, 2311, 10.1002/anie.199523111

Allen, 1983, Systematic analysis of structural data as a research technique in organic chemistry, Acc Chem Res, 16, 146, 10.1021/ar00089a001

Leiserowitz, 1976, Molecular packing modes. Carboxylic acids, Acta Crystallogr Section B, 32, 775, 10.1107/S0567740876003968

Bernstein, 1994, The role of hydrogen bonding in molecular assemblies, 431

Kuduva, 1999, Cubanecarboxylic acids. Crystal engineering considerations and the role of C═H···O hydrogen bonds in determining O═H···O networks, J Am Chem Soc, 121, 1936, 10.1021/ja981967u

http://www.rxlist.com/top200.htm. 30 of the top 100 selling drugs in the U.S. in 2002 contain carboxylic acids.

Allen, 1999, Systematic analysis of the probabilities of formation of bimolecular hydrogen-bonded ring motifs in organic crystal structures, New J Chem, 23, 25, 10.1039/a807212d

Steiner, 2001, Competition of hydrogen-bonded acceptors for the strong carboxyl donors, Acta Crystallogr, B57, 103, 10.1107/S0108768100014348

Sharma, 1996, X-ray structure of C6H3(CO2H)3-1,3,5·1.5(4,4′-bipy): A ‘super trimesic acid’ chicken-wire grid, Chem Commun, 2655, 10.1039/CC9960002655

Vishweshwar, 2002, Recurrence of carboxylic acid-pyridine supramolecular synthon in the crystal structures of some pyrazinecarboxylic acids, J Org Chem, 67, 556, 10.1021/jo0162484

Vishweshwar, 2003, Molecular complexes of homologous alkanedicarboxylic acids with isonicotinamide: X-ray crystal structures, hydrogen bond synthons, and melting point alternation, Cryst Growth Des, 3, 783, 10.1021/cg034037h

Bhogala, 2002, Fourfold inclined interpenetrated and threefold parallel interpenetrated hydrogen bonds networks in 1,3,5-cyclohexane tricarboxylic acid hydrate and its molecular complex with 4,4′-bipyridine, Cryst Growth Des, 2, 325, 10.1021/cg025537y

Aakeröy, 2002, A high-yielding supramolecular reaction, J Am Chem Soc, 124, 14425, 10.1021/ja027845q

Aakeröy, 2001, “Total synthesis” supramolecular style: Design and hydrogen-bond-directed assembly of ternary supermolecules, Angew Chem Int Ed, 40, 3240, 10.1002/1521-3773(20010903)40:17<3240::AID-ANIE3240>3.0.CO;2-X

Bhogala, 2003, Co-crystals of 1,3,5-cyclohexanetricarboxylic acid with 4,4′-bipyridine homologues: Acid···Pyridine hydrogen bonding in neutral and ionic complexes, Cryst Growth Des, 3, 547, 10.1021/cg034047i

Bond, 2003, In situ co-crystallization as a tool for low-temperature crystal engineering, Chem Commun, 250, 10.1039/b208904a

Ma, 2003, Formation of pyrene nano-rods within a supramolecular framework, Chem Commun, 2290, 10.1039/b306965f

Harkema, 1972, The crystal structure of urea oxalic acid (2:1), Acta Crystallogr B, 28, 1646, 10.1107/S0567740872004789

Leiserowitz, 1977, The molecule packing modes and the hydrogen-bonding properties of amide-dicarboxylic acid complexes, Acta Crystallogr, B33, 2719, 10.1107/S0567740877009376

Reddy, 2004, Phenyl-perfluorophenyl synthon mediated cocrystallization of carboxylic acids and amides, Cryst Growth Des, 4, 89, 10.1021/cg034106s

Aakeröy, 2003, Do polymorphic compounds make good cocrystallizing agents? A structural case study that demonstrates the importance of synthon flexibility, Cryst Growth Des, 3, 159, 10.1021/cg025593z

Ermer, 1994, Molecular recognition among alcohols and amines: Super-tetrahedral crystal architectures of linear diphenol–diamine complexes and aminophenols, J Chem Soc Perkin Trans, 2, 925, 10.1039/P29940000925

Hanessian, 2003, Crystal design: Structure and function, 77

Vangala, 2003, Correspondence between molecular functionality and crystal structures. Supramolecular chemistry of a family of homologated aminophenols, J Am Chem Soc, 125, 14495, 10.1021/ja037227p

Vishweshwar, 2003, Supramolecular synthons in phenol-isonicotinamide adducts, Cryst Eng Comm, 5, 164, 10.1039/B304078J

Papaefstathiou, 2001, Discrete versus infinite molecular self-assembly: Control in crystalline hydrogen-bonded assemblies based on resorcinol, Org Lett, 3, 3835, 10.1021/ol0165948

Biradha, 1998, A supramolecular analogue of cyclohexane sustained by aromatic C═H···π interactions: Complexes of 1,3,5-trihydroxybenzene with substituted pyridines, J Am Chem Soc, 120, 6431, 10.1021/ja974105m

Trask, 2005, Crystal engineering of organic cocrystals by the solid-state grinding approach, Top Curr Chem, 254, 41, 10.1007/b100995

Shan, 2002, Mechanochemistry and co-crystal formation: Effect of solvent on reaction kinetics, Chem Commun, 2372, 10.1039/b207369m

Trask, 2005, Selective polymorph transformation via solvent-drop grinding, Chem Commun, 880, 10.1039/b416980h

Bingham, 2001, Over one hundred solvates of sulfathiazole, Chem Commun, 603, 10.1039/b009540k

Stahl, 2002, Pharmaceutical aspects of the drug salt form

Berge, 1977, Pharmaceutical salts, J Pharm Sci, 66, 1, 10.1002/jps.2600660104

Remenar, 2003, Salt selection and simultaneous polymorphism assessment via high-throughput crystallization: The case sertraline, Org Process Res Dev, 7, 990, 10.1021/op034115+

Bhogala, 2005, Three-component carboxylic acid-bipyridine lattice inclusion host. Supramolecular synthesis of ternary cocrystals, Cryst Growth Des, 5, 1683, 10.1021/cg058012p

McCrone, 1965, Physics and chemistry of the solid state, 725

These statistics are solely based on the structures deposited in the CSD. There are also other hydrate and polymorphic single component and co-crystals that are not characterized through X-ray diffraction or not deposited in the CSD.

Bernstein, 2002

Bernsein, 1999, Concomitant polymorphs, Angew Chem Int Ed, 38, 3440, 10.1002/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO;2-#

Threlfall, 1995, Analysis of organic polymorphs. A review, Analyst, 120, 2435, 10.1039/an9952002435

Byrn, 1999

Vishweshwar, 2006, Crystal engineering of pharmaceutical co-crystals, 25

Higuchi, 1954, J Am Pharm Asso, 43, 393, 10.1002/jps.3030430704

Higuchi, 1954, J Am Pharm Asso, 43, 398, 10.1002/jps.3030430705

Guttman, 1955, Study of possible complex formation between macromolecules and certain pharmaceuticals IX. Formation of iodine-iodide complexes with polyethylene glycol, J Am Pharm Asso, 44, 668, 10.1002/jps.3030441108

Guttman, 1956, Possible complex formation between macromolecules and certain pharmaceuticals X. The interaction of some phenolic compounds with polyethylene glycols, polypropylene glycols, and polyvinylpyrrolidone, J Am Pharm Asso, 45, 659, 10.1002/jps.3030451002

Zerkowski, 1990, Design of organic structures in the solid state: Hydrogen-bonded molecular “Tapes”, J Am Chem Soc, 112, 9025, 10.1021/ja00180a083

Zerkowski, 1992, Solid-state structures of “Rosette” and “Crinkled Tape” motifs derived from the cyanuric acid-melamine lattice, J Am Chem Soc, 114, 5473, 10.1021/ja00039a096

Zerkowski, 1994, Steric control of secondary, solid-state architecture in 1:1 complexes of melamines and barbiturates that crystallize as crinckled tapes, J Am Chem Soc, 116, 4298, 10.1021/ja00089a019

Zerkowski, 1994, Design of organic structures in the solid state: Molecular tapes based on the network of hydrogen bonds present in the cyanuric acid·melamine complex, J Am Chem Soc, 116, 2382, 10.1021/ja00085a018

Zerkowski, 1994, New varities of crystlline archeticture produced by small changes in molecular structure in tape complexes of melamines and barbiturates, J Am Chem Soc, 116, 4305, 10.1021/ja00089a020

Vishweshwar, 2002, Supramolecular synthons based on N═H···N and C═H···O hydrogen bonds. Crystal engineering of a helical structure with 5,5-diethylbarbituric acid, Chem Commun, 1830, 10.1039/B204388B

Himes, 1981, Structure of carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamide, Acta Crystallogr, B37, 2242, 10.1107/S0567740881008522

Reboul, 1981, 5H-dibenz[b,f]axepine-5-carboxamide (carbamazepine), Acta Crystallogr, B37, 844

Lowes, 1987, Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine, J Pharm Sci, 76, 744, 10.1002/jps.2600760914

Lisgarten, 1989, Crystal and molecular structure of 5-carbamyl-5H-dibenz[b,f]azepine, J Crystallogr Spectrosc Res, 19, 641, 10.1007/BF01179836

Rustichelli, 2000, Solid-state study of polymorphic drugs: Carbamazepine, J Pharm Biomed Anal, 23, 41, 10.1016/S0731-7085(00)00262-4

Ceolin, 1997, X-ray characterization of the triclinic polymorph of carbamazepine, J Pharm Sci, 86, 1062, 10.1021/js960338k

Lang, 2002, Form IV of carbamazepine, J Pharm Sci, 91, 1186, 10.1002/jps.10093

Grzesiak, 2003, Comparison of the four anhydrous polymorphs of carbamazepine and crystal structure of form 1, J Pharm Sci, 92, 2260, 10.1002/jps.10455

Reck, 1986, The order-disorder structure of carbamazepine dihydrate: 5H-dibenz[b,f]azepine-5-carboxamide dihydrate, C15H12N2O·2H2O, Cryst Res Technol, 21, 1463, 10.1002/crat.2170211118

Reck, 1991, Crystal structures of the adducts carbamazepine-ammonium chloride and carbamazepine-ammonium bromide and their transformation to carbamazepine dihydrate, Pharmazie, 46, 509

Kobayashi, 2000, Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate, Int J Pharm, 193, 137, 10.1016/S0378-5173(99)00315-4

Leiserowitz, 1969, Molecular packing modes III. Primary amides, J Chem Soc, A16, 2372, 10.1039/j19690002372

MacDonald, 2000, The role of amides in the non-covalent synthesis of supramolecular structures in solution, at interfaces and in solids, 291

Meléndez, 1998, Hydrogen-bonded ribbons, tapes and sheets as motifs for crystal engineering, 97

Rodriguez-Spong, 2003, Enhancing the pharmaceutical behavior of carbamazepine through the formation of cocrystals, AAPS Pharm Sci, 5

Rodriguez-Spong, 2005

Scheuer, 1999, Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain, Pharmacopsychiatry, 32, 10, 10.1055/s-2007-979231

Gouliaev, 1994, Piracetam and other structurally related nootropics, Brain Res Rev, 19, 180, 10.1016/0165-0173(94)90011-6

Tacconi, 1986, Piracetam: Physiological disposition and mechanism of action, 675

Giurgea, 1967, A GABA-related hypothesis on the mechanism of action of the antimotion sickness drugs, Arch Int Pharmacodyn, 166, 238

Admiraal, 1982, Structures of the triclinic and monoclinic modifications of (2-oxo-1-pyrrolidinyl)acetamide, Acta Crystallogr, B38, 2600, 10.1107/S0567740882009431

Louer, 1995, Structure of metastable phase of piracetam from X-ray powder diffraction using the atom-atom potential method, Acta Crystallogr, B51, 182, 10.1107/S0108768194008840

Fabbiani, 2005, An exploration of the polymorphism of piracetam using high pressure, Cryst Eng Comm, 7, 179, 10.1039/b418976k

Kuhnert-Brandstaetter, 1994, Stability behavior of piracetam polymorphs, Scientia Pharm, 62, 307

Lorico, 1986, Gentisic acid: An aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes, Biochem Pharma, 35, 2443, 10.1016/0006-2952(86)90474-0

Ohsako, 1995, Effect of aspirin metabolites on pharmacokinetics of aspirin in human blood, Yakuzai, 55, 261

Cunha, 2001, The mechanism of gentisic acid-induced relaxation of the guinea pig isolated trachea: The role of potassium channels and vasoactive intestinal peptide receptors, Brazilian J Med Bio Res, 34, 381, 10.1590/S0100-879X2001000300013

Haisa, 1982, The structures of 2-hydroxy-5-methylbenzoic acid and dimorphs of 2,5-dihydroxybenzoic acid, Acta Crystallogr, B38, 1480, 10.1107/S0567740882006189

Luo, 2002, Engineering crystalline architecture with supramolecular tapes: Studies on secondary donor–acceptor interactions in cocrystals of the cyclic dipeptide of glycine, Cryst Growth Des, 2, 337, 10.1021/cg025535d

Aäkeroy, 1995, L-proline 2,5-dihydroxybenzoic acid (1/1):a zwitterion co-crystal, Acta Chem Scand, 49, 762, 10.3891/acta.chem.scand.49-0762

Mele, 2000, Noncovalent association phenomena of 2,5-dihydroxybenzoic acid with cyclic and liner oligosaccharides. A matrix-assisted laster desorption/ionization time-of-flight mass spectrometric and X-ray crystallographic study, J Am Soc Mass Spectrum, 11, 228, 10.1016/S1044-0305(99)00143-9

Refcodes: AJALAY, FURAOX, NEMTEE, RAHGEM, UNEZIW, UNEZOC, UNEZUI, UROXAM, XEWTIC and ZODWIY.

Hickey MB,Peterson ML,Scoppettuolo L,Vetter A,Guzmán H,Remenar JF,McMahon JA,Tawa MD,Almarsson Ö.Performance comparison of a novel co-crystal of carbamazepine with polymorphs and dihydrate forms. Private communication.

Giuseppetti, 1994, 1:1 Molecular complex of trimethoprim and sulfametrole, Acta Crystallogr, C50, 1289

Ishida, 1989, Structural study of histamine H2-receptor antagonists. Five 3-[2-(diaminomethyleneamino)-4-thiazolylmethylthio] propionamidine and amide derivatives, Acta Crystallogr, B45, 505, 10.1107/S0108768189006634

Caira, 1998, Structure of a 1:1 complex between the anthelmintic drug mebendazole and propionic acid, J Chem Crystallogr, 28, 11, 10.1023/A:1021766300133

Ladányi, 1999, Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate, Chirality, 11, :689, 10.1002/(SICI)1520-636X(1999)11:9<689::AID-CHIR4>3.0.CO;2-X

Ota, 1993, Conformational studies of semotiadil (Sd-3211), A Novel Ca2+ Antagonist, Chem Pharm Bull, 41, 1681, 10.1248/cpb.41.1681

Marubayashi, 1999, Crystal structure of 1-{2-[(p-chloro-alpha-phenylbenzyl)oxy]ethyl}piperidine fendizoate (Cloperastine fendizoate), Anal Sci, 15, 813, 10.2116/analsci.15.813

Hogberg, 1987, Crystallographic, theoretical and molecular modeling studies on the conformations of the salicylamide, raclopride, a selective dopamine-D2 antagonist, J Pharm Pharmacol, 39, 787, 10.1111/j.2042-7158.1987.tb05120.x

Furuya, 1989, Crystal structure and absolute-configuration of (−)-amosulalol L(+)-Hemitartrate, Anal Sci, 5, 489, 10.2116/analsci.5.489